Form 4: Intuitive Surgical Executive Robert DeSantis Executes Stock Options and Sells Shares Under 10b5-1 Trading Plan
SEC Form 4
Robert DeSantis, EVP & Chief Strategy & Corp Op at Intuitive Surgical, executed stock options and sold shares of ISRG common stock on March 8 and March 11, 2024, under a pre-arranged 10b5-1 trading plan.
Summary
- Robert DeSantis, an executive at Intuitive Surgical, engaged in transactions involving the company's stock on March 8 and March 11, 2024.
- These transactions involved the exercise of non-qualified stock options and the subsequent sale of common stock.
- The sales were executed under a pre-arranged trading plan that complies with SEC Rule 10b5-1, which is set to expire on December 9, 2024.
- The prices at which the shares were sold varied, with weighted average sale prices disclosed for each transaction date.
- Following these transactions, DeSantis still beneficially owns a significant amount of Intuitive Surgical common stock and derivative securities.
Sentiment
Score: 5
Explanation: The document is a routine disclosure of stock transactions by an executive, with no inherent positive or negative sentiment. The transactions are part of a pre-arranged plan, suggesting a neutral outlook.
Future Outlook
The executive's future transactions will likely continue to be governed by the existing 10b5-1 trading plan, which expires on December 9, 2024.
Industry Context
Executive stock transactions are a common occurrence in publicly traded companies and are often scrutinized by investors for insights into management's perspective on the company's valuation and future prospects. The use of a 10b5-1 trading plan provides a structured and transparent framework for these transactions, mitigating concerns about insider trading.
Comparison to Industry Standards
- Executive compensation practices, including stock options and trading plans, are common across the medical device industry.
- Companies like Stryker (SYK) and Medtronic (MDT) also utilize stock options as part of their executive compensation packages.
- The vesting schedules and exercise prices of Intuitive Surgical's stock options are generally in line with industry standards for incentivizing long-term performance.
- The use of a 10b5-1 trading plan is a standard practice to ensure compliance with insider trading regulations, similar to what is seen at other large publicly traded companies.
Key Dates
| Date | Description |
|---|---|
| 02/10/2023 | Date used to measure vesting for some stock options. |
| 08/10/2023 | Date used to measure vesting for some stock options. |
| 03/08/2024 | Date of multiple transactions involving stock option exercises and share sales. |
| 03/11/2024 | Date of multiple transactions involving stock option exercises and share sales. |
| 12/09/2024 | Expiration date of the Rule 10b5-1 trading plan. |
| 02/28/2029 | Expiration date for some non-qualified stock options. |
| 08/28/2029 | Expiration date for some non-qualified stock options. |
| 05/11/2030 | Expiration date for some non-qualified stock options. |
| 08/09/2030 | Expiration date for some non-qualified stock options. |
| 02/27/2030 | Expiration date for some non-qualified stock options. |
| 02/26/2031 | Expiration date for some non-qualified stock options. |
| 08/26/2031 | Expiration date for some non-qualified stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.